Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...

Precision-targeted therapy via antibody drugs has become central to the field of cancer immunotherapy. Monoclonal antibodies ...

A new 'nanobody' could be more effective than the antibodies currently used, targeting the brain rather than just reducing ...

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic ...

Leverages Kling’s technology to discover hard-to-find, immuno-functional antibodies from immortalized human B cells Accelerating discovery of first-in-class antibodies to transform disease prevention ...

Dr. Iwasaki is internationally recognized for her groundbreaking research on viral pathogenesis, human immunobiology, and post-viral chronic conditions, including Long COVID and COVID-19 ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can ...

In this video, Sham Mailankody, MBBS, discusses results from a first-in-human study of JNJ-5322, a next-generation trispecific antibody for treatment of patients with relapsed or refractory multiple ...